Independent research on the U.S. markets, Baptista Research

Baptista Research

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. 

We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul>
<li>Willis Towers Watson (WTW) reported its second quarter 2026 financial results marked by moderate organic revenue growth, expansion in operating margins, and a notable increase in adjusted diluted earnings per share compared to the prior year.</li>
<li>The company achieved 5% organic growth enterprise-wide, with particularly strong performance in the Risk &amp; Broking (R&amp;B) segment, which grew organically by 7%.</li>
<li>This segment benefited from broad-based strength across geographies and specialty lines, especially in North America’s construction, natural resources, surety, and M&amp;A sectors, despite a competitive pricing environment and generally declining insurance rates.</li>
</ul>


Willis Towers Watson (WTW) reported its second quarter 2026 financial results marked by moderate organic revenue growth, expansion in operating margins, and a notable increase in adjusted diluted earnings per share compared to the prior year.
The company achieved 5% organic growth enterprise-wide, with particularly strong performance in the Risk &amp; Broking (R&amp;B) segment, which grew organically by 7%.
This segment benefited from broad-based strength across geographies and specialty lines, especially in North America’s construction, natural resources, surety, and M&amp;A sectors, despite a competitive pricing environment and generally declining insurance rates.


Willis Towers Watson’s $400 Million AI Savings Plan — Can Margins Reach 30%?